University of Kansas Medical Center

Summary

University of Kansas Medical Center is a medical facility located in Mission, Kansas. This center is recognized for care of Lung Cancer, Acute Myeloid Leukemia, Pancreatic Cancer, Multiple Myeloma, Lymphoma and other specialties. University of Kansas Medical Center is involved with conducting 59 clinical trials across 83 conditions. There are 5 research doctors associated with this hospital, such as Andrea D. Jewell, Raed Al-Rajabi, Steve Williamson, MD, and OBI Investigator Site.

Top PIs

Clinical Trials running at University of Kansas Medical Center

Breast Cancer

Liver Cancer

Multiple Myeloma

Solid Tumors

Bladder Cancer

Cancer

Hepatocellular Carcinoma

Tumors

Chronic Lymphocytic Leukemia

Follicular Lymphoma

RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant

for Breast Cancer

This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment with a CDK4/6 inhibitor.

Recruiting

2 awards

Phase 3

5 criteria

[177Lu]Lu-NeoB + Ribociclib + Fulvestrant

for Breast Cancer

The purpose of this trial is to estimate the recommended dose (RD) of \[177Lu\]Lu-NeoB in combination with ribociclib and fulvestrant in participants with estrogen receptor (ER) positive (ER+), human epidermal growth factor receptor-2 (HER2) negative (HER2-) and gastrin releasing peptide receptor (GRPR) positive (GRPR+) advanced breast cancer experiencing early relapse from (neo)adjuvant endocrine therapy or who have progressed on endocrine therapy in combination with a CDK4/6 inhibitor for advanced disease.

Recruiting

1 award

Phase 1

6 criteria